-
Something wrong with this record ?
The effect of different molecular weight hyaluronan on macrophage physiology
D. Krejcova, M. Pekarova, B. Safrankova, L. Kubala
Language English Country Sweden
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
20027154
Knihovny.cz E-resources
- MeSH
- Macrophage Activation drug effects physiology MeSH
- Hyaluronan Receptors metabolism MeSH
- Cell Line MeSH
- Hyaluronic Acid chemistry metabolism pharmacology MeSH
- Lipopolysaccharides toxicity MeSH
- Macrophages chemistry drug effects physiology MeSH
- Molecular Weight MeSH
- Mice MeSH
- NF-kappa B metabolism MeSH
- Nitric Oxide metabolism MeSH
- Flow Cytometry MeSH
- Nitric Oxide Synthase Type II metabolism MeSH
- Tumor Necrosis Factor-alpha metabolism MeSH
- Toll-Like Receptor 2 metabolism MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVES: Hyaluronan, a linear glycosaminoglycan, is an abundant component of extracellular matrix. In its native form, the high-molar-mass hyaluronan polymers have an array of structural and regulatory, mainly anti-inflammatory and anti-angiogenic, functions. In contradiction, the biological effects of fragmented low molecular weight hyaluronan are suggested to be pro-angiogenic and pro-inflammatory. METHODS: The effects of highly purified pharmacological grade hyaluronan of defined molecular weights 11, 52, 87, 250 and 970 kilodaltons were tested on mouse macrophage cell lines RAW 264.7 and MHS. The surface expression of CD44 and Toll-like receptor 2, surface receptors for hyaluronan, was determined by flow cytometry. Activation of macrophages was determined based on nitric oxide and tumour necrosis factor alpha production, inducible nitric oxide synthase expression, and the activation of the nuclear factor kappa B transcriptional factor. RESULTS: Both macrophage cell lines expressed CD44 and Toll-like receptor 2, which were significantly increased by the pre-treatment of macrophages with bacterial lipopolysaccharide. Hyaluronan of any molecular weight did not activate production of nitric oxide or tumour necrosis factor alpha in any mouse macrophage cell lines. Correspondingly, hyaluronan of any tested molecular weight did not stimulate nuclear factor kappa B activation. Similarly, hyaluronan of any molecular weight neither exerted stimulatory nor inhibitory effects on macrophages pre-treated by lipopolysaccharide. CONCLUSION: Interestingly, the data does not support the current view of low molecular weight hyaluronan as a pro-inflammatory mediator for macrophages. Further studies are necessary to clarify the effects of different molecular weight hyaluronan on phagocytes.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025386
- 003
- CZ-PrNML
- 005
- 20130128214420.0
- 007
- ta
- 008
- 120816s2009 sw f 000 0#eng||
- 009
- AR
- 035 __
- $a (PubMed)20027154
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Viačková, Daniela, $d 1981- $7 _AN067095 $u Academy of Sciences of the Czech Republic, Brno, Czech Republic.
- 245 14
- $a The effect of different molecular weight hyaluronan on macrophage physiology / $c D. Krejcova, M. Pekarova, B. Safrankova, L. Kubala
- 520 9_
- $a OBJECTIVES: Hyaluronan, a linear glycosaminoglycan, is an abundant component of extracellular matrix. In its native form, the high-molar-mass hyaluronan polymers have an array of structural and regulatory, mainly anti-inflammatory and anti-angiogenic, functions. In contradiction, the biological effects of fragmented low molecular weight hyaluronan are suggested to be pro-angiogenic and pro-inflammatory. METHODS: The effects of highly purified pharmacological grade hyaluronan of defined molecular weights 11, 52, 87, 250 and 970 kilodaltons were tested on mouse macrophage cell lines RAW 264.7 and MHS. The surface expression of CD44 and Toll-like receptor 2, surface receptors for hyaluronan, was determined by flow cytometry. Activation of macrophages was determined based on nitric oxide and tumour necrosis factor alpha production, inducible nitric oxide synthase expression, and the activation of the nuclear factor kappa B transcriptional factor. RESULTS: Both macrophage cell lines expressed CD44 and Toll-like receptor 2, which were significantly increased by the pre-treatment of macrophages with bacterial lipopolysaccharide. Hyaluronan of any molecular weight did not activate production of nitric oxide or tumour necrosis factor alpha in any mouse macrophage cell lines. Correspondingly, hyaluronan of any tested molecular weight did not stimulate nuclear factor kappa B activation. Similarly, hyaluronan of any molecular weight neither exerted stimulatory nor inhibitory effects on macrophages pre-treated by lipopolysaccharide. CONCLUSION: Interestingly, the data does not support the current view of low molecular weight hyaluronan as a pro-inflammatory mediator for macrophages. Further studies are necessary to clarify the effects of different molecular weight hyaluronan on phagocytes.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antigeny CD44 $x metabolismus $7 D018960
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a kyselina hyaluronová $x chemie $x metabolismus $x farmakologie $7 D006820
- 650 _2
- $a lipopolysacharidy $x toxicita $7 D008070
- 650 _2
- $a aktivace makrofágů $x účinky léků $x fyziologie $7 D008262
- 650 _2
- $a makrofágy $x chemie $x účinky léků $x fyziologie $7 D008264
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a molekulová hmotnost $7 D008970
- 650 _2
- $a NF-kappa B $x metabolismus $7 D016328
- 650 _2
- $a oxid dusnatý $x metabolismus $7 D009569
- 650 _2
- $a synthasa oxidu dusnatého, typ II $x metabolismus $7 D052247
- 650 _2
- $a toll-like receptor 2 $x metabolismus $7 D051195
- 650 _2
- $a TNF-alfa $x metabolismus $7 D014409
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pekarová, Michaela, $d 1982-2019 $7 mub2011659519
- 700 1_
- $a Šafránková, Barbora
- 700 1_
- $a Kubala, Lukáš, $d 1973- $7 xx0094314
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 30 Suppl 1(2009), s. 106-111
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20027154 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20130128214604 $b ABA008
- 999 __
- $a ok $b bmc $g 947428 $s 782732
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2009 $b 30 Suppl 1 $d 106-111 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20120816/10/02